he addition of pertuzumab to the treatment regimen of docetaxel and trastuzumab increases a patient’s risk of: decreased renal function and clearance, increased central and peripheral neuropathies, increased hepatocellular toxicites, decreased left ventricular ejection fraction
[Expert Solution]: he addition of pertuzumab to the treatment…
Need help with your Renal, Fluid & Electrolytes case study or NCLEX preparation? Connect with a verified Nursing expert now.